NCT00139334View on ClinicalTrials.gov

A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh

PHASE2CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

January 31, 2006

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL

Rotavirus

Trial Locations (1)

1000

GSK Investigational Site, Dhaka

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00139334 - A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh | Biotech Hunter | Biotech Hunter